CAS 106939-34-8

Éster ácido de levofloxacino

Descripción:

Éster ácido de levofloxacino, con el número CAS 106939-34-8, es un derivado de levofloxacino, que es un antibiótico fluoroquinolona. Este compuesto exhibe propiedades antibacterianas, dirigiéndose principalmente a la girasa del ADN bacteriano y a la topoisomerasa IV, que son esenciales para la replicación y transcripción del ADN bacteriano. Éster ácido de levofloxacino se caracteriza por su capacidad para inhibir el crecimiento de un amplio espectro de bacterias Gram-positivas y Gram-negativas, lo que lo hace efectivo en el tratamiento de diversas infecciones. El compuesto se administra típicamente en su forma activa, y su farmacocinética puede verse influenciada por factores como la solubilidad y la estabilidad. En términos de propiedades físicas, Éster ácido de levofloxacino es generalmente un sólido cristalino, con puntos de fusión y ebullición específicos que pueden variar según la pureza y la formulación. La seguridad y la eficacia son consideraciones críticas en su uso, y es esencial monitorear posibles efectos secundarios, incluidos trastornos gastrointestinales y efectos en el sistema nervioso central. En general, Éster ácido de levofloxacino desempeña un papel significativo en la terapia antimicrobiana, particularmente en el tratamiento de infecciones respiratorias y del tracto urinario.

Fórmula: C₁₅H₁₃F₂NO₄

InChI: InChI=1/C15H13F2NO4/c1-3-21-15(20)9-5-18-7(2)6-22-14-11(17)10(16)4-8(12(14)18)13(9)19/h4-5,7H,3,6H2,1-2H3/t7-/m0/s1

Clave InChI: InChIKey=TZSXJUSNOOBBOP-ZETCQYMHSA-N

SMILES: O=C1C=2C=3N(C=C1C(OCC)=O)[C@@H](C)COC3C(F)=C(F)C2

Sinónimos:

• 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, ethyl ester, (3S)-
• 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, ethyl ester, (S)-
• Difluorocarboylic Acid Este
• Ethyl (3S)-9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate
• Ethyl (S)-9,10-Difluoro-3-Methyl-7-Oxo-2,3-Dihydro-7H-Pyrido[1,2,3-De]-1,4-Benzoxazine-6-Carboxylate
• Ethyl 9,10-difluoro-3-(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate
• ethyl (3S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
• Levofloxacin cyclization ester
• Ethyl (S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido
• 9,10-Difluoro-3-(S)-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate
• Levofloxacin carboxylic acid, ethyl ester
• 7h-Pyrido[1,2,3-De]-1,4-Benzoxazine-6-Carboxylic Acid
• (S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Ethyl Ester
• (S)-Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxyla
• carboxylate
• (S)-Ethyl 9,10-difluoro-3-Methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate
• Levofloxacin Impurity 5
• (S)-Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carbox
• oxo-2,3-dihydro-7H-
• ethyl (S)-9,10-difluoro-3-methyl-7-
• (3S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacidethylester
• 7H-PYRIDO[1,2,3-DE]-1,4-BENZOXAZINE-6-CARBOXYLIC ACID, 9,10-DIFLUORO-2,3-DIHYDRO-3-METHYL-7-OXO-, ETHYL ESTER
• [1,4]oxazino[2,3,4-ij]quinoline-6-

7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-3-methyl-7-oxo-, ethyl ester, (3s)-

CAS: 106939-34-8

Fórmula: C₁₅H₁₃F₂NO₄

Pureza: 98%

Forma y color: Solid

Peso molecular: 309.2648

Ref: IN-DA007TQ0

(S)-Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate

CAS: 106939-34-8

(S)-Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate

Pureza: 98%

Peso molecular: 309.268g/mol

Ref: 54-PC99767

Levofloxacin Impurity 10

CAS: 106939-34-8

Fórmula: C₁₅H₁₃F₂NO₄

Forma y color: White To Off-White Solid

Peso molecular: 309.27

Ref: 4Z-L-2326

(S)-Ethyl 9,10-difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate

CAS: 106939-34-8

Pureza: 95.0%

Forma y color: Solid

Peso molecular: 309.2690124511719

Ref: 10-F223912

(S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Ethyl Ester

CAS: 106939-34-8

Forma y color: Neat

Ref: 86-MM0846.14

(S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Ethyl Ester

Producto controlado

CAS: 106939-34-8

Fórmula: C₁₅H₁₃F₂NO₄

Forma y color: Off-White To Light Yellow

Peso molecular: 309.26

Ref: TR-D445748

Levofloxacin Impurity 10

CAS: 106939-34-8

Fórmula: C₁₅H₁₃F₂NO₄

Peso molecular: 309.3

Ref: ST-EA-CP-L17026

(S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ethyl ester

CAS: 106939-34-8

(S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid ethyl ester is an acidic substance that can be produced by the amination of piperazine with chloroacetic acid. The reaction solution is heated to a temperature of about 120°C for about 30 minutes and then cooled to room temperature. The product precipitates as a white solid. This compound has been shown to have antibacterial activity against methicillin resistant Staphylococcus aureus (MRSA) in plates.

Fórmula: C₁₅H₁₃F₂NO₄

Pureza: Min. 95%

Peso molecular: 309.26 g/mol

Ref: 3D-FD21854